Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-06-06 AccNo: 0001193805-17-001023 Size: 46 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-05-30 AccNo: 0001193805-17-000934 Size: 75 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-05-25 AccNo: 0001193805-17-000928 Size: 37 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-12 AccNo: 0001193805-17-000815 Size: 2 MB 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-05-12 AccNo: 0001193805-17-000814 Size: 64 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-05-10 AccNo: 0001193805-17-000756 Size: 57 KB 网页链接
$ADMA Biologics Inc(ADMA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-05-10 AccNo: 0001193805-17-000756 Size: 57 KB 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001193805-17-000755 Size: 46 KBItem 8.01: Other Events 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001193805-17-000755 Size: 46 KBItem 8.01: Other Events 网页链接
$ADMA Biologics Inc(ADMA)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-04-26 AccNo: 0001193805-17-000696 Size: 4 MB 网页链接